A Safety and Feasibility Study of Bevacizumab With Paclitaxel, Carboplatin and Chest Radiotherapy in Patients With Locally Advanced Non-Small Lung Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Mar 2014 Biomarkers information updated
- 23 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 23 Jan 2013 Actual initiation date changed from Aug 2005 to Jun 2006 as reported by ClinicalTrials.gov.